Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Interleukin-10 receptor (IL-10R) is a type II cytokine receptor that mediates the biological effects of interleukin-10 (IL-10), a key anti-inflammatory cytokine. IL-10R plays a crucial role in regulating immune responses, particularly by limiting and terminating inflammatory processes. It is a tetrameric complex composed of two α subunits (IL-10R1/IL10RA) and two β subunits (IL-10R2/IL10RB). Upon ligand binding, JAK1 and TYK2 kinases activate STAT3, driving transcription of anti-inflammatory genes. Defects can result in severe early-onset IBD. It is explored as a therapeutic target for autoimmune diseases, tissue damage repair, and cancer immunotherapy modulation.
Modulation of IL-10 signaling pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-10 Receptor (None).